AlphaStocks
6.8
Consider Buy

MASIMO CORP (MASI)

Health Care / Health Care Equipment

S&P MidCap 400

$178.80

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#105out of 1125 in Health Care

Is MASIMO CORP a Good Investment in 2026?

MASIMO CORP (MASI) scores 6.8 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates MASIMO CORP as Strong (7/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. MASIMO CORP currently trades above its estimated fair value of $91, suggesting limited upside at current prices. MASIMO CORP ranks #105 out of 1125 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE41.8Market Cap9B

Estimated Fair Value

$90.9097% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Neutral

Top half (rank 36%)

Frequently Asked Questions

Is MASIMO CORP (MASI) a good investment?
Based on AlphaStocks' composite analysis, MASIMO CORP (MASI) scores 6.8 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading above estimated fair value — the market may be pricing in future growth.
What is MASIMO CORP's Piotroski F-Score?
MASIMO CORP's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MASI overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $91, MASI appears overvalued. The stock currently trades 97% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does MASI compare to other Health Care stocks?
MASIMO CORP ranks #105 out of 1125 stocks in the Health Care sector, placing it in the top 9% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about MASI?
AlphaStocks evaluates MASI using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 6.8/10.

Similar Stocks

BFAMAZNKLIC

Compare MASI with

MASI vs BFAMMASI vs AZNMASI vs KLIC

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer